secwatch.observer — SEC 8-K summary
======================================

Issuer:     P3 Health Partners Inc. (PIII)
CIK:        0001832511
Form:       8-K
Filed at:   2024-05-08T23:59:59+00:00
Accession:  0001628280-24-021663
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

P3 Health Partners Q1 revenue up 29% to $388.5M; appoints Dr. Aric Coffman as CEO
--------------------------------------------------------------------------------

- Total revenue $388.5M (+29% YoY); capitated revenue $384.1M; net loss improved to $49.6M from $52.4M.
- Medical margin $36.6M vs $39.2M prior year; gross profit fell to $6.4M from $16.5M.
- Reaffirms FY2024 guidance: revenue $1.45-1.55B, medical margin $230-250M, adjusted EBITDA $20-40M.
- Dr. Aric Coffman appointed CEO; company anticipates reaching adjusted EBITDA positive in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024021663/0001628280-24-021663-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832511/000162828024021663/piii-20240508.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-021663

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer